CD2 and systemic mastocytosis: D816V KIT mutation was less frequently detected in advanced SM compared to non-advanced variants (p < 0.001) Moreover, also the aberrant expression of CD25 and/or CD2 was more frequent in non-advanced SM than in advanced ones (p < 0.001).